Circulating tumor DNA predicts tumor progression and poor survival in patients with stage III melanoma. Palacios-Diaz RD, de Unamuno-Bustos B, Carratala-Garcia A, Perez-Simo G, et al. Melanoma Res 2025 May 19. doi: 10.1097/CMR.0000000000001041.

Read + Share

Amedeo Smart

Independent Medical Education

Palacios-Diaz RD, de Unamuno-Bustos B, Carratala-Garcia A, Perez-Simo G, et al. Circulating tumor DNA predicts tumor progression and poor survival in patients with stage III melanoma. Melanoma Res 2025 May 19. doi: 10.1097/CMR.0000000000001041.
PMID: 40387867